🇺🇸 UTHR — United Therapeutics Corporation
Salud CompraPrecio actual
565,72 USD
Máx. histórico
608,49
1 días
Split 2:1 del 23/09/2009
Caída desde máximo
-7,03%
Rango 52 semanas
444,04 – 614,23
Variación hoy
-7,03%
Cierre anterior
608,49
Rango de hoy
561,24 – 608,04
Volumen hoy
602.001
Peor caída histórica
-93,18%
12/07/2000 → 10/12/2001
Recuperado en 3311 días
Volatilidad anualizada ⓘ
46,96%
- Nombre completo
- United Therapeutics Corporation
- Divisa
- USD
- Mercado
- NasdaqGS
- Sector
- Salud
- Industria
- Drug Manufacturers - Specialty & Generic
- Empleados
- 1.400
- PER ⓘ
- 21,36 (puede no estar actualizado)
- Dividend yield
- 0,00% (puede no estar actualizado)
- Precio objetivo analistas
- 670,93 USD (puede no estar actualizado)
- Primera cotización
- 17/06/1999
- Precio actualizado
- hace 7 horas
United Therapeutics Corporation engages in the development and commercialization of products to address the unmet medical needs of patients with chronic and life-threatening diseases in the United States and internationally. It offers Tyvaso DPI, an inhaled dry powder via pre-filled and single-use cartridges; Nebulized Tyvaso, an inhaled solution via ultrasonic nebulizer; Remodulin (treprostinil) injection to treat patients with pulmonary arterial hypertension to diminish symptoms associated with exercise; Orenitram, a tablet dosage form of treprostinil, to delay disease progression and improve exercise capacity in PAH patients; and Adcirca, an oral PDE-5 inhibitor to enhance the exercise ability in PAH patients. It also markets and sells Unituxin (dinutuximab) injection, a monoclonal antibody for high-risk neuroblastoma; and Remunity Pump, which contains a pump and separate controller for Remodulin. In addition, it is involved in developing RemunityPRO Pump and Ralinepag for the treatment of PAH;and Nebulized Tyvaso, for the treatment of idiopathic pulmonary fibrosis, as well as xenografts, which are development-stage organ products. Further, it provides preclinical products, including EVLP/CLES, for lung transplant; UKidney, UHeart, UThymoKidney, a development-stage gene-edited porcine kidneys and hearts for xenotransplantation; ULobe, for allogeneic regenerative medicine; ULung, for autologous regenerative medicine; IVIVA Kidney, for autologous regenerative medicine; miroliver, for allogeneic regenerative medicine; and mirokidney, for allogeneic regenerative medicine. It has licensing and collaboration agreements with DEKA Research & Development Corp. to develop a semi-disposable system for the subcutaneous delivery of treprostinil; MannKind Corporation to develop and license treprostinil inhalation powder and the Dreamboat device; and Arena Pharmaceuticals, Inc. to develop Ralinepag. The company was founded in 1996 and is headquartered in Silver Spring, Maryland.
| Fecha | Ratio |
|---|---|
| 23/09/2009 | 2:1 |
| Fecha | Apertura | Máximo | Mínimo | Cierre | Variación | Volatilidad día | Volumen |
|---|---|---|---|---|---|---|---|
| 17/12/2013 | 88,50 | 88,50 | 85,73 | 85,89 | -2,88% | 3,13% | 647.500 |
| 16/12/2013 | 88,32 | 90,19 | 88,05 | 88,44 | +0,28% | 2,42% | 417.800 |
| 13/12/2013 | 91,19 | 91,27 | 87,99 | 88,19 | -2,71% | 3,60% | 545.300 |
| 12/12/2013 | 89,80 | 91,12 | 89,27 | 90,65 | +0,77% | 2,06% | 438.000 |
| 11/12/2013 | 91,81 | 91,95 | 89,72 | 89,96 | -1,97% | 2,43% | 625.600 |
| 10/12/2013 | 90,43 | 92,50 | 89,72 | 91,77 | +1,45% | 3,07% | 783.500 |
| 09/12/2013 | 89,73 | 91,37 | 89,28 | 90,46 | -0,56% | 2,33% | 444.300 |
| 06/12/2013 | 89,98 | 91,11 | 88,93 | 90,97 | +1,94% | 2,42% | 596.000 |
| 05/12/2013 | 90,74 | 90,74 | 88,63 | 89,24 | -1,63% | 2,33% | 946.600 |
| 04/12/2013 | 92,83 | 93,18 | 90,60 | 90,72 | -2,94% | 2,78% | 1.108.400 |
| 03/12/2013 | 95,00 | 95,23 | 92,74 | 93,47 | -1,56% | 2,62% | 850.600 |
| 02/12/2013 | 92,82 | 95,10 | 91,92 | 94,95 | +2,86% | 3,43% | 645.200 |
| 29/11/2013 | 91,55 | 92,90 | 91,12 | 92,31 | +0,84% | 1,94% | 241.800 |
| 27/11/2013 | 92,67 | 93,47 | 90,97 | 91,54 | -0,86% | 2,70% | 672.700 |
| 26/11/2013 | 92,93 | 93,24 | 91,86 | 92,33 | -0,67% | 1,48% | 405.300 |
| 25/11/2013 | 93,50 | 94,38 | 92,66 | 92,95 | -0,42% | 1,84% | 382.900 |
| 22/11/2013 | 93,06 | 94,04 | 92,76 | 93,34 | +0,80% | 1,38% | 275.700 |
| 21/11/2013 | 92,12 | 93,00 | 91,33 | 92,60 | +1,05% | 1,81% | 697.600 |
| 20/11/2013 | 92,78 | 93,16 | 91,08 | 91,64 | -1,00% | 2,24% | 277.100 |
| 19/11/2013 | 91,27 | 93,22 | 90,87 | 92,57 | +1,31% | 2,57% | 452.800 |
| 18/11/2013 | 93,98 | 94,22 | 91,02 | 91,37 | -2,80% | 3,40% | 408.100 |
| 15/11/2013 | 93,21 | 94,17 | 92,08 | 94,00 | +1,01% | 2,24% | 320.800 |
| 14/11/2013 | 92,00 | 93,52 | 91,48 | 93,06 | +1,54% | 2,22% | 505.000 |
| 13/11/2013 | 92,82 | 93,66 | 91,02 | 91,65 | -1,67% | 2,84% | 465.900 |
| 12/11/2013 | 92,23 | 93,39 | 91,13 | 93,21 | +1,47% | 2,45% | 533.300 |
| 11/11/2013 | 90,30 | 92,12 | 89,71 | 91,86 | +1,55% | 2,67% | 665.500 |
| 08/11/2013 | 87,92 | 91,97 | 87,92 | 90,46 | +3,23% | 4,61% | 566.100 |
| 07/11/2013 | 90,48 | 91,20 | 87,53 | 87,63 | -2,56% | 4,06% | 645.900 |
| 06/11/2013 | 89,83 | 90,80 | 88,43 | 89,93 | -0,20% | 2,64% | 692.900 |
| 05/11/2013 | 89,15 | 90,47 | 88,05 | 90,11 | +0,45% | 2,71% | 666.800 |